Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1613 1617 1672 3786
This examiner grants 60% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18577720 | TABLET COMPRISING A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID | Non-Final OA | Novo Nordisk A/S |
| 17593514 | MOUSSE PRODUCTS, METHODS AND DEVICES | Non-Final OA | Honeywell International Inc. |
| 18681600 | COMPOSITION FOR GENERATING NITROGEN MONOXIDE | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
| 18378720 | BUFFERED ADHESIVE COMPOSITIONS FOR SKIN-ADHERING MEDICAL PRODUCTS | Non-Final OA | HOLLISTER INCORPORATED |
| 18595636 | COSMETIC | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 17294947 | DRIED BIOLOGICAL COMPOSITIONS AND METHODS THEREOF | Non-Final OA | Evonik Operations GmbH |
| 18673481 | BIOCOMPATIBLE MATERIAL AND METHODS FOR MAKING AND USING THEREOF | Non-Final OA | The Hong Kong University of Science and Technology |
| 18577485 | SELF-PROPELLED PHARMACEUTICAL DELIVERY CAPSULES | Non-Final OA | Cochlear Limited |
| 17285743 | Bioadhesive for Soft Tissue Repair | Final Rejection | Northeastern University |
| 18696874 | COMPOSITIONS COMPRISING OR2AT4 AGONISTS | Non-Final OA | Coty Inc. |
| 18259836 | STABLE EFFICIENT COSMETIC PREPARATIONS | Non-Final OA | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. |
| 18265867 | AN ANTIPERSPIRANT COMPOSITION | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18037359 | TOPICAL SANITISING COMPOSITION COMPRISING MINIMAL AMOUNTS OF AN ANTIMICROBIAL LIPID | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 18751708 | SKIN TREATMENT METHODS AND COMPOSITIONS FOR TRANSDERMAL DELIVERY OF ACTIVE AGENTS | Non-Final OA | Topix Pharmaceuticals, Inc. |
| 17928003 | 3-HYDROXYBUTYRIC-ACID-CONTAINING OIL AND FAT COMPOSITION | Final Rejection | OSAKA GAS CO., LTD. |
| 18702383 | COMPOSITION COMPRISING GELATIN, GELATIN FILMS AND CAPSULES | Non-Final OA | Tessenderlo Group NV |
| 18692208 | ACTIVE INGREDIENT DELIVERY SYSTEM | Non-Final OA | OPES CORPORATION OY |
| 18597717 | ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS | Non-Final OA | Jazz Pharmaceuticals Research UK Limited |
| 18681812 | AN IMPROVED PROCESS FOR THE PREPARATION OF AN AQUEOUS OPHTHALMIC SOLUTION OF DIFLUPREDNATE | Non-Final OA | SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED |
| 18528153 | ENCAPSULATION OF LIPOPHILIC INGREDIENTS IN DISPERSIBLE SPRAY DRIED POWDERS SUITABLE FOR INHALATION | Non-Final OA | Flurry Powders, LLC |
| 18564563 | PAIN RELIEF PATCH | Non-Final OA | CS MEDICA A/S |
| 18156058 | Phosphorylated Tri-Block Copolymers with Anti-Microbial Properties | Non-Final OA | UChicago Argonne, LLC |
| 18501422 | High-Potency Vitamin C Topical Formulations | Final Rejection | MF Beauty Partners LLC |
| 18285645 | FORMULATION AND METHOD FOR TREATMENT OF URINARY SYSTEM DISORDERS | Non-Final OA | WATERSHED MEDICAL INC |
| 18553657 | A NANOFORMULATION FOR GLIOMA TREATMENT AND PROCESS FOR ITS PREPARATION THEREOF | Non-Final OA | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH |
| 18549330 | PULLULAN CAPSULES | Final Rejection | Capsugel Belgium NV |
| 17920346 | HPMC CAPSULE WITH REDUCED POWDER RETENTION | Final Rejection | Capsugel Belgium NV |
| 18279916 | GRANULES CONTAINING AN ACTIVE SUBSTANCE, METHOD FOR PREPARING SAME AND USE THEREOF IN FOOD FOR HUMAN CONSUMPTION OR ANIMAL FEED | Non-Final OA | CAPSULAE |
| 18276540 | Pectin Compositions and Methods of Use | Non-Final OA | The Brigham and Women`s Hospital, Inc. |
| 18275214 | MEDICAL TISSUE ADHESIVE AND PREPARATION METHOD THEREOF | Non-Final OA | HAINING ZHULUOJI BIOTECHNOLOGY CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy